Stock Taper
SCREENER COMPARE ANY 2 STOCKS
SILO
SILO PHARMA, INC.
NASDAQ
$2.54
▲ UP 0.00% (0.00)

KEY STATISTICS

Market Cap$2.87 M
52w High$15.15
52w Low$2.43
Dividend Yield—
Frequency—
P/E-0.82
Volume18.09K
Shares Out.1.13M

COMPANY

LEADERSHIP

Eric Weisblum
CHIEF EXECUTIVE
Eric Weisblum

COMPENSATION 2026

Salary$350,000
Stock Awards$0
Incentive Plan Pay$0
All Other Comp.$80,051
Total$630,051

ABOUT

SECTOR
Healthcare
WENT PUBLIC
January 8, 2021
METHOD OF GOING PUBLIC
IPO
FULL TIME EMPLOYEES
3

UPCOMING EARNINGS

DateDec 2, 2026
DayWednesday
Rev. Est.$18.00K
DEC
2
WED

SPLIT RECORD

DATETYPERATIO
2026-06-03Reverse1:15
2022-09-19Reverse1:50
2022-09-15Reverse1:50

PRICE

$2.54 ▲ UP 0.00% (+$0.00)
OVERLAYS
$2.49$2.52$2.55$2.589:30 AM10:35 AM11:40 AM12:45 PM1:49 PM2:54 PM3:59 PM2.54

About Silo Pharma, Inc.

https://silopharma.com ↗

Silo Pharma Inc. is a biopharmaceutical company developing therapies, including psychedelic and traditional treatments, for underserved CNS disorders like PTSD, chronic pain, Alzheimer's, and MS, through innovative formulations and collaborations.

INDUSTRY

Biotechnology

A PRODUCT SILO PHARMA, INC. IS KNOWN FOR

SPC-15
SPC-15

SPC-15, Silo Pharma's lead intranasal therapy for PTSD and stress-related disorders, is advancing toward clinical trials with recent patent allowances.

COMPETITORS

COMPETITOR
ATAI COMPARE
CMPS COMPARE
GHRS COMPARE

ETFS HOLDING THIS STOCK

ETFS HOLDING
2
LISTED HERE
2
RANKED BY POSITION SIZE
PSIL
0.41% · 90.5K
VXF
0.00% · 12.0K

INSTITUTIONAL OWNERSHIP

SHARES OWNED
100.00%
HOLDERS
22
TOP 12 OF 22 · RANKED BY POSITION SIZE
Anson Funds Management LP
952.4K sh · $657.14K
Advisorshares Investments LLC
664.0K sh · $238.83K
Drw Securities, LLC
333.7K sh · $113.47K
Geode Capital Management, LLC
180.0K sh · $64.76K
Virtu Financial LLC
107.8K sh · $74K
Susquehanna International Group, Llp
62.8K sh · $22.59K
Xtx Topco Ltd
56.9K sh · $19.35K
Jane Street Group, LLC
44.8K sh · $16.1K
Vanguard Group Inc
24.3K sh · $8.27K
Citadel Advisors LLC
21.4K sh · $7.71K
Two Sigma Securities, LLC
16.5K sh · $11.37K
Stonex Group Inc.
13.4K sh · $9.27K

RATINGS SNAPSHOT

Overall rating: C+

DCFROEROAD/EP/EP/B
Discounted Cash Flow5
Return On Equity1
Return On Assets1
Debt To Equity1
Price To Earnings1
Price To Book4
Overall Score2

INSIDER TRADES

★
DIRECTOR, OFFICER: CHIEF EXECUTIVE OFFICER
Weisblum Eric
Purchase · 2.5K shares
2025-12-15
★
DIRECTOR, OFFICER: CHIEF EXECUTIVE OFFICER
Weisblum Eric
Purchase · 1.0K shares
2025-11-21
★
DIRECTOR, OFFICER: CHIEF EXECUTIVE OFFICER
Weisblum Eric
Purchase · 4.5K shares
2025-11-19
★
DIRECTOR, OFFICER: CHIEF EXECUTIVE OFFICER
Weisblum Eric
Purchase · 7.5K shares
2025-11-18

SECTORS PEERS

PEERPRICE
KZIA$13.58COMPARE
CNSP$5.52COMPARE
SNGX$0.38COMPARE
CMND$1.76COMPARE
INM$1.38COMPARE
BDRX$0.87COMPARE
GRI$1.92COMPARE
JAGX$0.81COMPARE